In re HIV Antitrust Litigation
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA San Francisco Division PETER STALEY, et al., Case No. 19-cv-02573-EMC (LB)
Plaintiffs,
DISCOVERY ORDER
v. Re: ECF No. 1210 GILEAD SCIENCES, INC., et al., Defendants. 16 INTRODUCTION AND STATEMENT The parties’ primary dispute concerns the adequacy of written discovery responses from a subsidiary of the Retailer Plaintiff, CVS Pharmacy Inc. (CVS). The defendants (Gilead Sciences, Inc., Gilead Sciences, LLC, and Teva Pharmaceuticals USA, Inc.) asked the court to order CaremarkPCS Health, L.L.C. (CVS Caremark/Caremark), a wholly owned pharmacy-benefit manager (PBM) subsidiary of Retailer Plaintiff CVS, to produce all documents that are responsive to the defendants’ requests for production within two days and produce a Rule 30(b)(6) witness for a deposition within fourteen days after the production.1 25
1 Joint Disc. Ltr. – ECF No. 1210 at 2–4 (filed under seal at ECF No. 1209-2). Citations refer to…